HUP0402160A3 - T-cell epitodes in carboxypeptidase g2 - Google Patents

T-cell epitodes in carboxypeptidase g2

Info

Publication number
HUP0402160A3
HUP0402160A3 HU0402160A HUP0402160A HUP0402160A3 HU P0402160 A3 HUP0402160 A3 HU P0402160A3 HU 0402160 A HU0402160 A HU 0402160A HU P0402160 A HUP0402160 A HU P0402160A HU P0402160 A3 HUP0402160 A3 HU P0402160A3
Authority
HU
Hungary
Prior art keywords
epitodes
carboxypeptidase
cell
cell epitodes
Prior art date
Application number
HU0402160A
Other languages
English (en)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HUP0402160A2 publication Critical patent/HUP0402160A2/hu
Publication of HUP0402160A3 publication Critical patent/HUP0402160A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HU0402160A 2001-11-29 2002-11-27 T-cell epitodes in carboxypeptidase g2 HUP0402160A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP01128519 2001-11-29
EP02001778 2002-01-25
EP02020634 2002-09-13
PCT/EP2002/013351 WO2003045426A1 (en) 2001-11-29 2002-11-27 T-cell epitodes in carboxypeptidase g2

Publications (2)

Publication Number Publication Date
HUP0402160A2 HUP0402160A2 (hu) 2005-01-28
HUP0402160A3 true HUP0402160A3 (en) 2007-05-02

Family

ID=27224249

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0402160A HUP0402160A3 (en) 2001-11-29 2002-11-27 T-cell epitodes in carboxypeptidase g2

Country Status (12)

Country Link
US (1) US20050074863A1 (hu)
EP (1) EP1501540A1 (hu)
JP (1) JP2005510227A (hu)
KR (1) KR20040068561A (hu)
CN (1) CN1592633A (hu)
AU (1) AU2002352162A1 (hu)
BR (1) BR0214567A (hu)
CA (1) CA2468501A1 (hu)
HU (1) HUP0402160A3 (hu)
MX (1) MXPA04004970A (hu)
PL (1) PL369735A1 (hu)
WO (1) WO2003045426A1 (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008279550B2 (en) * 2007-06-21 2012-08-09 Angelica Therapeutics, Inc. Modified toxins
EP2268297A4 (en) * 2008-02-29 2011-11-16 Angelica Therapeutics Inc MODIFIED TOXINS
JP2016519651A (ja) 2013-03-15 2016-07-07 アンジェリカ セラピューティックス，インク． 改質された毒素
GB201308363D0 (en) 2013-05-09 2013-06-19 Bagshawe Kenneth D Tumour therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656718B2 (en) * 2000-07-07 2003-12-02 Cancer Research Technology Limited Modified carboxypeptidase enzymes and their use
WO2002069232A2 (en) * 2001-02-19 2002-09-06 Merck Patent Gmbh Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity

Also Published As

Publication number Publication date
CA2468501A1 (en) 2003-06-05
EP1501540A1 (en) 2005-02-02
US20050074863A1 (en) 2005-04-07
WO2003045426A1 (en) 2003-06-05
AU2002352162A1 (en) 2003-06-10
PL369735A1 (en) 2005-05-02
BR0214567A (pt) 2004-12-28
MXPA04004970A (es) 2004-08-11
KR20040068561A (ko) 2004-07-31
CN1592633A (zh) 2005-03-09
JP2005510227A (ja) 2005-04-21
HUP0402160A2 (hu) 2005-01-28

Similar Documents

Publication Publication Date Title
GB0016844D0 (en) Nanoparticles
GB2380672B (en) Herbal formulation
GB2378384B (en) Herbal formulation
GB0127466D0 (en) Improvements in footwear
AU2002365035A8 (en) Direct mailing device
GB2378385B (en) Herbal formulation
HUP0402160A3 (en) T-cell epitodes in carboxypeptidase g2
EP1321151A4 (en) MEANS FOR THE TREATMENT OF PARKINSON
GB0107628D0 (en) Substances
GB0114533D0 (en) Substances
GB0115071D0 (en) Substances
ZA200405149B (en) T-cell epitodes in carboxypeptidase G2.
GB0106031D0 (en) Use
GB0116185D0 (en) Substances
GB2359781B (en) Publication
GB2379887B (en) Improvements in slides
GB0107630D0 (en) Substances
GB0116184D0 (en) Substances
GB0120235D0 (en) Substances
GB0126402D0 (en) Substances
GB0121187D0 (en) Substances
GB0205241D0 (en) Five in one
CA90215S (en) Enclosed slide
GB0123487D0 (en) Two in one
PL345558A1 (en) Herb flovouring

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees